March 21, 2025 - 13:09

A woman from New South Wales has successfully appealed her conviction for hitting her 13-year-old son during a heated argument over a technology ban. The incident occurred when the mother attempted to enforce rules regarding her son's use of electronic devices, which led to a physical confrontation. Initially, the court found her guilty, resulting in a conviction that sparked significant public debate about parental discipline and the boundaries of acceptable behavior.
In her appeal, the woman argued that her actions were a momentary lapse in judgment and that she was trying to guide her son in a challenging situation. The appeal court ultimately sided with her, recognizing the complexities surrounding parenting and discipline in the digital age. This case highlights the ongoing discussions about the role of technology in family dynamics and the often fine line between discipline and abuse. The outcome has prompted conversations about how parents navigate rules and consequences in a world dominated by screens and devices.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...